Clemence Merlen
Montreal, QC, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications
Clinical Value of Kidney Immunodeposits and Urinary Complement Activation Fragments in IgAN.
Journal: Kidney international reports
Published: March 02, 2026
Immunoglobulin Isotype Profiling of Anti-Factor H Autoantibodies in Complement-Mediated Diseases.
Journal: International journal of laboratory hematology
Published: January 12, 2026
Immune Deposits, Complement Activation, and APOL1 Risk Variants in Focal Segmental Glomerulosclerosis.
Journal: American journal of nephrology
Published: December 17, 2025
Comparison of Three ELISA Assays for the Detection and Quantification of Autoantibodies Against Complement Factor H.
Journal: International journal of laboratory hematology
Published: July 18, 2025
Macrothrombocytopaenia: More to Fear Than Just Low Platelet Count.
Journal: Haemophilia : the official journal of the World Federation of Hemophilia
Published: July 08, 2025
The impact of the COVID-19 pandemic on incidence and clinical presentation of thrombotic microangiopathies: data from a laboratory centralizing ADAMTS-13 testing in Quebec.
Journal: Orphanet journal of rare diseases
Published: February 07, 2025
Clinical Significance of Immune Deposits and Complement System Activation in FSGS: Findings from the Cure Glomerulonephropathy Network Study.
Journal: Kidney360
Published: December 25, 2024
Understanding the impact of nuclear-localized GPCRs on cellular signalling.
Journal: Cellular signalling
Published: July 24, 2024
Unraveling the Role of Complement in Focal Segmental Glomerulosclerosis Pathogenesis: Insights and Challenges.
Journal: Kidney international reports
Published: March 19, 2024
A Prospective Study on Complement Activation Distinguishes Focal Segmental Glomerulosclerosis from Minimal Change Disease.
Journal: Kidney international reports
Published: November 08, 2023
Switching to emicizumab: A prospective surveillance study in haemophilia A subjects with inhibitors.
Switching to emicizumab: A prospective surveillance study in haemophilia A subjects with inhibitors.
Journal: Haemophilia : the official journal of the World Federation of Hemophilia
Published: June 09, 2022
Incidence of thrombotic microangiopathies in Quebec: insight from a laboratory centralizing ADAMTS-13 testing.
Journal: Orphanet journal of rare diseases
Published: January 13, 2022
Last Updated: 09/26/2026